Formoterol
Composition
Contains Formoterol fumarate, a long-acting β2-adrenergic agonist (LABA).
Indications
Used for long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD); not for acute symptom relief.
Side effects
Tremor, headache, palpitations, throat irritation, muscle cramps.
Precautions
Should always be used with an inhaled corticosteroid in asthma; monitor for paradoxical bronchospasm and cardiovascular effects.
Contraindications
Monotherapy in asthma, hypersensitivity to formoterol.
Dosage and administration
DPI: 12 mcg inhaled twice daily; Nebulized solution (COPD): 20 mcg twice daily.
Countries
Mexico, Brazil
Available Forms
Dry powder inhaler (DPI), nebulizer solution, combination inhalers with corticosteroids or anticholinergics.